Lesley A. Saketkoo
Advanced in Pulmonary Fibrosis

Dr. Lesley A. Saketkoo

Rheumatology | Pediatrics
1542 Tulane Ave, 
New Orleans, LA 
Accepting New Patients
Advanced in Pulmonary Fibrosis
1542 Tulane Ave, 
New Orleans, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lesley Saketkoo is a Rheumatologist and a Pediatrics provider in New Orleans, LA. Dr. Saketkoo is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. Her top areas of expertise are Sarcoidosis, Scleroderma, Systemic Sclerosis (SSc), and Pulmonary Hypertension. Dr. Saketkoo is currently accepting new patients.

Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of Pulmonary Fibrosis.

Specialties
Rheumatology
Pediatrics
Licenses
Internal Medicine in LA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

University Medical Center New Orleans
1542 Tulane Ave, New Orleans, LA 70112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 06, 2025
Intervention Type: Drug
Study Drug: HZN-825
Study Phase: Phase 2
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 3 Less Clinical Trials

109 Total Publications

Response to "Concerns Regarding PTX-3 Specificity and ROC Interpretation in the Study on Endothelial Biomarkers of SSc-Associated Pulmonary Hypertension".
Response to "Concerns Regarding PTX-3 Specificity and ROC Interpretation in the Study on Endothelial Biomarkers of SSc-Associated Pulmonary Hypertension".
Journal: Arthritis care & research
Published: May 29, 2025
Similar Doctors
Jay K. Kolls
Experienced in Pulmonary Fibrosis
Dr. Jay K. Kolls
Pediatrics | Pulmonary Medicine | Pediatric Pulmonology
Experienced in Pulmonary Fibrosis
Dr. Jay K. Kolls
Pediatrics | Pulmonary Medicine | Pediatric Pulmonology
200 Henry Clay Ave, 
New Orleans, LA 
 (3.9 miles away)
504-988-0456
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jay Kolls is a Pediatrics specialist and a Pulmonary Medicine provider in New Orleans, Louisiana. Dr. Kolls is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Pneumonia, Pneumocystis Jiroveci Pneumonia, Allergic Bronchopulmonary Aspergillosis, Cystic Fibrosis, and Lung Transplant. Dr. Kolls is currently accepting new patients.

Experienced in Pulmonary Fibrosis
Dr. Louis D. Perdue
Rheumatology
Experienced in Pulmonary Fibrosis
Dr. Louis D. Perdue
Rheumatology

Arthritis And Rheumatology Of Metairie, Apmc

4315 Houma Blvd, Suite 303, 
Metairie, LA 
 (7.4 miles away)
504-889-5242
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Louis Perdue is a Rheumatologist in Metairie, Louisiana. Dr. Perdue is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Felty Syndrome, Fibromyalgia, Gout, and Rheumatoid Arthritis (RA). Dr. Perdue is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Saketkoo's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile